deltatrials
Completed OBSERVATIONAL NCT04443231

Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation

Sponsor: Peking University Third Hospital

Updated 4 times since 2020 Last updated: Jun 22, 2020 Started: Nov 1, 2018 Primary completion: Oct 1, 2019 Completion: Oct 1, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Adolescent and Adult and is currently completed. Peking University Third Hospital leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jul 2020 — Jan 2021 [monthly]

    Completed

    First recorded

Nov 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Peking University Third Hospital
Data source: Peking University Third Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations